A5060080248- Acupuncture Treatment Research Studies
- Botulinum Toxin and Related Neurological Disorders
- Multiple Sclerosis Research Studies
- Cerebral Palsy and Movement Disorders
- Parkinson's Disease Mechanisms and Treatments
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Dysphagia Assessment and Management
- Alzheimer's disease research and treatments
- Olfactory and Sensory Function Studies
- Diet and metabolism studies
- Family and Patient Care in Intensive Care Units
- Voice and Speech Disorders
- Traumatic Brain Injury Research
- Tracheal and airway disorders
- Myofascial pain diagnosis and treatment
- Intensive Care Unit Cognitive Disorders
- Transcranial Magnetic Stimulation Studies
- Telemedicine and Telehealth Implementation
- Stroke Rehabilitation and Recovery
- Dementia and Cognitive Impairment Research
- Liver Disease Diagnosis and Treatment
- Traditional Chinese Medicine Studies
- Neurological disorders and treatments
- Sleep and related disorders
- Gut microbiota and health
Heilongjiang University of Chinese Medicine
2024-2025
The First Affiliated Hospital, Sun Yat-sen University
2017
Zhongshan Hospital
2017
Fudan University
2017
Sun Yat-sen University
2017
Kessler Foundation
2015
Abstract Objectives : Nonalcoholic Fatty Liver Disease (NAFLD) is a metabolic disease syndrome with progressive development leading to cirrhosis and liver cancer. Electroacupuncture (EA) non-pharmacological therapy. The aim of this systematic review assess the efficacy safety electroacupuncture in treatment NAFLD. Design Systematic meta- analysis. Data sources: A comprehensive database search was conducted using PubMed, Embase, Cochrane Library, Web Science, Cnki, Wan Fang, VIP identify...
To assess the efficacy of modafinil for treatment new learning and memory deficits fatigue in multiple sclerosis. Only 1 previous study literature, to our knowledge, examined effect on cognition specifically persons with sclerosis.Sixteen patients a diagnosis sclerosis (MS) documented impairment completed study. In 5-week randomized, double-blinded, crossover design, participants received either single daily oral dose (200 mg) or placebo 2 weeks. A 1-week washout period was included between...